ReP USP - Resultado da busca

Artigo de periodico
Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats (2024)
Souza, Aline de ; Scarim, Cauê Benito ; Cotrim, Paulo César ; Barbosa Junior, Fernando ; Rocha, Bruno Alves ; Calixto, Leandro Augusto ; Correia, Cristiano de Jesus; Araujo, Gabriel Lima Barros de ; Löbenberg, Raimar ; Bou-Chacra, Nadia Araci ; Faloppa, Ana Cristina Breithaupt
Source: Nanomedicine. Unidades: FM, FCFRP, FCF
Subjects: LEISHMANIA, SISTEMA LINFÁTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Aline de et al. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, v. 19, n. 4, p. 293-301, 2024Tradução . . Disponível em: https://dx.doi.org/10.2217/nnm-2023-0263. Acesso em: 10 nov. 2024.
APA
Souza, A. de, Scarim, C. B., Cotrim, P. C., Barbosa Junior, F., Rocha, B. A., Calixto, L. A., et al. (2024). Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, 19( 4), 293-301. doi:10.2217/nnm-2023-0263
NLM
Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 nov. 10 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
Vancouver
Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 nov. 10 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
Artigo de periodico
Nutraceutical composition (yeast β-glucan, prebiotics, minerals, and silymarin) predicts improvement of sleep quality and metabolic parameters: a randomized pilot study (2024)
Santamarina, Aline Boveto; Nehmi Filho, Victor; Freitas, Jéssica Alves de ; Silva, Bruna Fernanda Rio Branco da; Gusmao, Arianne Fagotti; Olivieri, Eloísa Helena Ribeiro; Souza, Erica de; Silva, Sabrina Lira da; Miranda, Danielle Araujo de; Demarque, Daniel Pecoraro ; Oliveira, Eduarda dos Santos; Otoch, José Pinhata ; Pessoa, Ana Flávia Marçal
Source: Clinical Nutrition ESPEN. Unidades: FCF, FM
Subjects: PREBIÓTICOS, QUALIDADE DE VIDA, SUPLEMENTOS DIETÉTICOS, INFLAMAÇÃO, SONO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTAMARINA, Aline Boveto et al. Nutraceutical composition (yeast β-glucan, prebiotics, minerals, and silymarin) predicts improvement of sleep quality and metabolic parameters: a randomized pilot study. Clinical Nutrition ESPEN, v. 63, p. 476-490, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.clnesp.2024.06.033. Acesso em: 10 nov. 2024.
APA
Santamarina, A. B., Nehmi Filho, V., Freitas, J. A. de, Silva, B. F. R. B. da, Gusmao, A. F., Olivieri, E. H. R., et al. (2024). Nutraceutical composition (yeast β-glucan, prebiotics, minerals, and silymarin) predicts improvement of sleep quality and metabolic parameters: a randomized pilot study. Clinical Nutrition ESPEN, 63, 476-490. doi:10.1016/j.clnesp.2024.06.033
NLM
Santamarina AB, Nehmi Filho V, Freitas JA de, Silva BFRB da, Gusmao AF, Olivieri EHR, Souza E de, Silva SL da, Miranda DA de, Demarque DP, Oliveira E dos S, Otoch JP, Pessoa AFM. Nutraceutical composition (yeast β-glucan, prebiotics, minerals, and silymarin) predicts improvement of sleep quality and metabolic parameters: a randomized pilot study [Internet]. Clinical Nutrition ESPEN. 2024 ; 63 476-490.[citado 2024 nov. 10 ] Available from: https://dx.doi.org/10.1016/j.clnesp.2024.06.033
Vancouver
Santamarina AB, Nehmi Filho V, Freitas JA de, Silva BFRB da, Gusmao AF, Olivieri EHR, Souza E de, Silva SL da, Miranda DA de, Demarque DP, Oliveira E dos S, Otoch JP, Pessoa AFM. Nutraceutical composition (yeast β-glucan, prebiotics, minerals, and silymarin) predicts improvement of sleep quality and metabolic parameters: a randomized pilot study [Internet]. Clinical Nutrition ESPEN. 2024 ; 63 476-490.[citado 2024 nov. 10 ] Available from: https://dx.doi.org/10.1016/j.clnesp.2024.06.033
Artigo de periodico
Factors associated with higher quality of clinical practice guidelines and their recommendations for the pharmacological treatment of depression: a systematic review (2023)
Gabriel, Franciele Cordeiro ; Melo, Daniela Oliveira de ; Stein, Airton Tetelbom ; Mota, Géssica Caroline Henrique Fontes ; Santos, Itamires Benício dos ; Rodrigues, Camila da Silva ; Rodrigues, Mônica Cristiane ; Ribeiro, Tatiane Bomfim ; Fráguas Junior, Renério ; Florez, Ivan D ; Correia, Diogo Telles ; Ribeiro, Eliane
Source: BMJ Open. Unidades: FM, FCF, FSP
Subjects: DEPRESSÃO, DIRETRIZES PARA A PRÁTICA CLÍNICA, FARMACOLOGIA CLÍNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GABRIEL, Franciele Cordeiro et al. Factors associated with higher quality of clinical practice guidelines and their recommendations for the pharmacological treatment of depression: a systematic review. BMJ Open, v. 13, n. 3, p. 1-8, 2023Tradução . . Disponível em: https://doi.org/10.1136/bmjopen-2022-067390. Acesso em: 10 nov. 2024.
APA
Gabriel, F. C., Melo, D. O. de, Stein, A. T., Mota, G. C. H. F., Santos, I. B. dos, Rodrigues, C. da S., et al. (2023). Factors associated with higher quality of clinical practice guidelines and their recommendations for the pharmacological treatment of depression: a systematic review. BMJ Open, 13( 3), 1-8. doi:10.1136/bmjopen-2022-067390
NLM
Gabriel FC, Melo DO de, Stein AT, Mota GCHF, Santos IB dos, Rodrigues C da S, Rodrigues MC, Ribeiro TB, Fráguas Junior R, Florez ID, Correia DT, Ribeiro E. Factors associated with higher quality of clinical practice guidelines and their recommendations for the pharmacological treatment of depression: a systematic review [Internet]. BMJ Open. 2023 ; 13( 3): 1-8.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1136/bmjopen-2022-067390
Vancouver
Gabriel FC, Melo DO de, Stein AT, Mota GCHF, Santos IB dos, Rodrigues C da S, Rodrigues MC, Ribeiro TB, Fráguas Junior R, Florez ID, Correia DT, Ribeiro E. Factors associated with higher quality of clinical practice guidelines and their recommendations for the pharmacological treatment of depression: a systematic review [Internet]. BMJ Open. 2023 ; 13( 3): 1-8.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1136/bmjopen-2022-067390
Artigo de periodico
Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats (2023)
Souza, Aline de ; Almeida, Maria Karilly Lima de; Barbosa, João Antonio; Yukuyama, Megumi Nishitani ; Correia, Cristiano de Jesus; Faloppa, Ana Cristina Breithaupt ; Bou-Chacra, Nadia Araci ; Calixto, Leandro Augusto
Source: Chemistry Africa. Unidades: FM, FCF
Subjects: TRYPANOSOMA CRUZI, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Aline de et al. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats. Chemistry Africa, v. 6, p. 837-843, 2023Tradução . . Disponível em: https://doi.org/10.1007/s42250-022-00547-6. Acesso em: 10 nov. 2024.
APA
Souza, A. de, Almeida, M. K. L. de, Barbosa, J. A., Yukuyama, M. N., Correia, C. de J., Faloppa, A. C. B., et al. (2023). Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats. Chemistry Africa, 6, 837-843. doi:10.1007/s42250-022-00547-6
NLM
Souza A de, Almeida MKL de, Barbosa JA, Yukuyama MN, Correia C de J, Faloppa ACB, Bou-Chacra NA, Calixto LA. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats [Internet]. Chemistry Africa. 2023 ; 6 837-843.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s42250-022-00547-6
Vancouver
Souza A de, Almeida MKL de, Barbosa JA, Yukuyama MN, Correia C de J, Faloppa ACB, Bou-Chacra NA, Calixto LA. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats [Internet]. Chemistry Africa. 2023 ; 6 837-843.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s42250-022-00547-6
Parte de monografia/livro
Beta-lactam agents serum measurements by liquid chromatography to evaluate meropenem and piperacillin effectiveness in septic burn adults with a pharmacokinetic-pharmacodynamic approach (2023)
Kupa, Leonard de Vinci Kanda ; Souza, Vanessa Kasubeck de ; Camargo, Thais Vieira de ; Messiano, Claudia Garcia ; Morales Júnior, Ronaldo ; Porta, Valentina ; Yonamine, Maurício ; Paranhos, Beatriz Aparecida Passos Bismara ; Abad, Aline Sandré Gomides ; Ferreira, Gabriela Aparecida; Campos, Edvaldo Vieira de ; Silva Junior, Elson Mendes da ; Silva Júnior, João Manoel da; Pinto, Débora Cristina Sanches ; Gómez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Chromatographic Methods and Research. Unidades: FCF, FM
Subjects: CROMATOGRAFIA LÍQUIDA, FARMACODINÂMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KUPA, Leonard de Vinci Kanda et al. Beta-lactam agents serum measurements by liquid chromatography to evaluate meropenem and piperacillin effectiveness in septic burn adults with a pharmacokinetic-pharmacodynamic approach. Chromatographic Methods and Research. Tradução . New York: Nova Science Publishers, 2023. . . Acesso em: 10 nov. 2024.
APA
Kupa, L. de V. K., Souza, V. K. de, Camargo, T. V. de, Messiano, C. G., Morales Júnior, R., Porta, V., et al. (2023). Beta-lactam agents serum measurements by liquid chromatography to evaluate meropenem and piperacillin effectiveness in septic burn adults with a pharmacokinetic-pharmacodynamic approach. In Chromatographic Methods and Research. New York: Nova Science Publishers.
NLM
Kupa L de VK, Souza VK de, Camargo TV de, Messiano CG, Morales Júnior R, Porta V, Yonamine M, Paranhos BAPB, Abad ASG, Ferreira GA, Campos EV de, Silva Junior EM da, Silva Júnior JM da, Pinto DCS, Gómez D de S, Santos SRCJ. Beta-lactam agents serum measurements by liquid chromatography to evaluate meropenem and piperacillin effectiveness in septic burn adults with a pharmacokinetic-pharmacodynamic approach. In: Chromatographic Methods and Research. New York: Nova Science Publishers; 2023. [citado 2024 nov. 10 ]
Vancouver
Kupa L de VK, Souza VK de, Camargo TV de, Messiano CG, Morales Júnior R, Porta V, Yonamine M, Paranhos BAPB, Abad ASG, Ferreira GA, Campos EV de, Silva Junior EM da, Silva Júnior JM da, Pinto DCS, Gómez D de S, Santos SRCJ. Beta-lactam agents serum measurements by liquid chromatography to evaluate meropenem and piperacillin effectiveness in septic burn adults with a pharmacokinetic-pharmacodynamic approach. In: Chromatographic Methods and Research. New York: Nova Science Publishers; 2023. [citado 2024 nov. 10 ]
Artigo de periodico
Guidelines’ recommendations for the treatment-resistant depression: a systematic review of their quality (2023)
Gabriel, Franciele Cordeiro ; Stein, Airton Tetelbom ; Melo, Daniela Oliveira de ; Mota, Gessica Caroline Henrique Fontes ; Santos, Itamires Benício dos ; Rodrigues, Camila da Silva; Dourado, Andrea; Rodrigues, Mônica Cristiane; Fraguas Junior, Renerio ; Florez, Ivan D ; Correia, Diogo Telles ; Ribeiro, Eliane
Source: Plos One. Unidades: FM, FCF
Subjects: DEPRESSÃO, ANTIDEPRESSIVOS, REVISÃO SISTEMÁTICA, DIRETRIZES PARA A PRÁTICA CLÍNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GABRIEL, Franciele Cordeiro et al. Guidelines’ recommendations for the treatment-resistant depression: a systematic review of their quality. Plos One, v. 18, n. 2 p. 1-10 art. e0281501, 2023Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0281501. Acesso em: 10 nov. 2024.
APA
Gabriel, F. C., Stein, A. T., Melo, D. O. de, Mota, G. C. H. F., Santos, I. B. dos, Rodrigues, C. da S., et al. (2023). Guidelines’ recommendations for the treatment-resistant depression: a systematic review of their quality. Plos One, 18( 2 p. 1-10 art. e0281501). doi:10.1371/journal.pone.0281501
NLM
Gabriel FC, Stein AT, Melo DO de, Mota GCHF, Santos IB dos, Rodrigues C da S, Dourado A, Rodrigues MC, Fraguas Junior R, Florez ID, Correia DT, Ribeiro E. Guidelines’ recommendations for the treatment-resistant depression: a systematic review of their quality [Internet]. Plos One. 2023 ; 18( 2 p. 1-10 art. e0281501):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1371/journal.pone.0281501
Vancouver
Gabriel FC, Stein AT, Melo DO de, Mota GCHF, Santos IB dos, Rodrigues C da S, Dourado A, Rodrigues MC, Fraguas Junior R, Florez ID, Correia DT, Ribeiro E. Guidelines’ recommendations for the treatment-resistant depression: a systematic review of their quality [Internet]. Plos One. 2023 ; 18( 2 p. 1-10 art. e0281501):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1371/journal.pone.0281501
Artigo de periodico
Recommendations for the pharmacological treatment of treatment-resistant depression: a systematic review protocol (2022)
Gabriel, Franciele Cordeiro; Stein, Airton Tetelbom ; Melo, Daniela Oliveira de ; Mota, Géssica Caroline Henrique Fontes; Santos, Itamires Benício dos ; Rodrigues, Camila da Silva; Rodrigues, Mônica Cristiane ; Fráguas, Renério ; Florez, Ivan D ; Correa, Diogo Telles ; Ribeiro, Eliane
Source: Plos One. Unidades: FM, FCF
Subjects: DEPRESSÃO, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GABRIEL, Franciele Cordeiro et al. Recommendations for the pharmacological treatment of treatment-resistant depression: a systematic review protocol. Plos One, v. 17, n. 4, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0267323. Acesso em: 10 nov. 2024.
APA
Gabriel, F. C., Stein, A. T., Melo, D. O. de, Mota, G. C. H. F., Santos, I. B. dos, Rodrigues, C. da S., et al. (2022). Recommendations for the pharmacological treatment of treatment-resistant depression: a systematic review protocol. Plos One, 17( 4), 1-10. doi:10.1371/journal.pone.0267323
NLM
Gabriel FC, Stein AT, Melo DO de, Mota GCHF, Santos IB dos, Rodrigues C da S, Rodrigues MC, Fráguas R, Florez ID, Correa DT, Ribeiro E. Recommendations for the pharmacological treatment of treatment-resistant depression: a systematic review protocol [Internet]. Plos One. 2022 ; 17( 4): 1-10.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1371/journal.pone.0267323
Vancouver
Gabriel FC, Stein AT, Melo DO de, Mota GCHF, Santos IB dos, Rodrigues C da S, Rodrigues MC, Fráguas R, Florez ID, Correa DT, Ribeiro E. Recommendations for the pharmacological treatment of treatment-resistant depression: a systematic review protocol [Internet]. Plos One. 2022 ; 17( 4): 1-10.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1371/journal.pone.0267323
Artigo de periodico
Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns (2022)
Messiano, Claudia Garcia; Morales Júnior, Ronaldo ; Pereira, Gabriela Otofuji; Silva Junior, Elson Mendes da; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Clinical Therapeutics. Unidades: FCF, FM
Subjects: QUEIMADURAS, FARMACODINÂMICA, FARMACOCINÉTICA, SEPSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MESSIANO, Claudia Garcia et al. Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns. Clinical Therapeutics, v. 44, p. 624-629, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2022.02.007. Acesso em: 10 nov. 2024.
APA
Messiano, C. G., Morales Júnior, R., Pereira, G. O., Silva Junior, E. M. da, Gomez, D. de S., & Santos, S. R. C. J. (2022). Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns. Clinical Therapeutics, 44, 624-629. doi:10.1016/j.clinthera.2022.02.007
NLM
Messiano CG, Morales Júnior R, Pereira GO, Silva Junior EM da, Gomez D de S, Santos SRCJ. Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns [Internet]. Clinical Therapeutics. 2022 ; 44 624-629.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.clinthera.2022.02.007
Vancouver
Messiano CG, Morales Júnior R, Pereira GO, Silva Junior EM da, Gomez D de S, Santos SRCJ. Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns [Internet]. Clinical Therapeutics. 2022 ; 44 624-629.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.clinthera.2022.02.007
Artigo de periodico
Medications adverse effects on voice: comparison between different sources of information (2022)
Cardoso, Leonardo da Rocha; Zenari, Marcia Simões ; Aguiar, Patrícia Melo ; Nemr, Katia
Source: Journal of Voice. Unidades: FM, FCF
Assunto: MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Leonardo da Rocha et al. Medications adverse effects on voice: comparison between different sources of information. Journal of Voice, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jvoice.2022.12.005. Acesso em: 10 nov. 2024.
APA
Cardoso, L. da R., Zenari, M. S., Aguiar, P. M., & Nemr, K. (2022). Medications adverse effects on voice: comparison between different sources of information. Journal of Voice. doi:10.1016/j.jvoice.2022.12.005
NLM
Cardoso L da R, Zenari MS, Aguiar PM, Nemr K. Medications adverse effects on voice: comparison between different sources of information [Internet]. Journal of Voice. 2022 ;[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.jvoice.2022.12.005
Vancouver
Cardoso L da R, Zenari MS, Aguiar PM, Nemr K. Medications adverse effects on voice: comparison between different sources of information [Internet]. Journal of Voice. 2022 ;[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.jvoice.2022.12.005
Artigo de periodico
Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum (2022)
Monteiro, Lis Marie ; Löbenberg, Raimar ; Barbosa, Eduardo José ; Araujo, Gabriel Lima Barros de ; Sato, Paula Keiko ; Kanashiro, Edite Hatsumi Yamashiro ; Eliodoro, Raissa Heloisa de Araujo; Rocha, Mussya; Freitas, Vera Lucia Teixeira de ; Fotaki, Nikoletta; Bou-Chacra, Nadia Araci
Source: European Journal of Pharmaceutical Sciences. Unidades: FCF, IMT, FM
Subjects: LIPÍDEOS, LEISHMANIOSE VISCERAL, DOENÇAS NEGLIGENCIADAS, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEIRO, Lis Marie et al. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum. European Journal of Pharmaceutical Sciences, v. 169, p. 1-11 art. 106097, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2021.106097. Acesso em: 10 nov. 2024.
APA
Monteiro, L. M., Löbenberg, R., Barbosa, E. J., Araujo, G. L. B. de, Sato, P. K., Kanashiro, E. H. Y., et al. (2022). Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum. European Journal of Pharmaceutical Sciences, 169, 1-11 art. 106097. doi:10.1016/j.ejps.2021.106097
NLM
Monteiro LM, Löbenberg R, Barbosa EJ, Araujo GLB de, Sato PK, Kanashiro EHY, Eliodoro RH de A, Rocha M, Freitas VLT de, Fotaki N, Bou-Chacra NA. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 169 1-11 art. 106097.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.ejps.2021.106097
Vancouver
Monteiro LM, Löbenberg R, Barbosa EJ, Araujo GLB de, Sato PK, Kanashiro EHY, Eliodoro RH de A, Rocha M, Freitas VLT de, Fotaki N, Bou-Chacra NA. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 169 1-11 art. 106097.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.ejps.2021.106097
Artigo de periodico
Pharmacokinetic and pharmacodynamic characteristics of vancomycin and meropenem in critically Ill patients receiving sustained lowefficiency dialysis (2020)
Oliveira, Maura Salaroli de; Machado, Anna Silva; Mendes, Elisa Teixeira; Chaves, Lucas; Perdigão Neto, Lauro Vieira; Silva Junior, Carlindo Vieira da; Santos, Silvia Regina Cavani Jorge ; Sanches, Cristina; Macedo, Etienne; Levin, Anna Sara Shafferman
Source: Clinical Therapeutics. Unidades: FCF, FM
Subjects: FARMACOCINÉTICA, FARMACODINÂMICA, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Maura Salaroli de et al. Pharmacokinetic and pharmacodynamic characteristics of vancomycin and meropenem in critically Ill patients receiving sustained lowefficiency dialysis. Clinical Therapeutics, v. 42, p. N. 4 625-633, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2020.02.011. Acesso em: 10 nov. 2024.
APA
Oliveira, M. S. de, Machado, A. S., Mendes, E. T., Chaves, L., Perdigão Neto, L. V., Silva Junior, C. V. da, et al. (2020). Pharmacokinetic and pharmacodynamic characteristics of vancomycin and meropenem in critically Ill patients receiving sustained lowefficiency dialysis. Clinical Therapeutics, 42, N. 4 625-633. doi:10.1016/j.clinthera.2020.02.011
NLM
Oliveira MS de, Machado AS, Mendes ET, Chaves L, Perdigão Neto LV, Silva Junior CV da, Santos SRCJ, Sanches C, Macedo E, Levin ASS. Pharmacokinetic and pharmacodynamic characteristics of vancomycin and meropenem in critically Ill patients receiving sustained lowefficiency dialysis [Internet]. Clinical Therapeutics. 2020 ; 42 N. 4 625-633.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.clinthera.2020.02.011
Vancouver
Oliveira MS de, Machado AS, Mendes ET, Chaves L, Perdigão Neto LV, Silva Junior CV da, Santos SRCJ, Sanches C, Macedo E, Levin ASS. Pharmacokinetic and pharmacodynamic characteristics of vancomycin and meropenem in critically Ill patients receiving sustained lowefficiency dialysis [Internet]. Clinical Therapeutics. 2020 ; 42 N. 4 625-633.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.clinthera.2020.02.011
Artigo de periodico
Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against grampositive pathogens? (2020)
Pires, Frederico Ribeiro; Paula, Stefano Ivani de; Delgado, Artur Figueiredo ; Carvalho, Werther Brunow de ; Duarte, Nilo José Coelho; Morales Júnior, Ronaldo; Santos, Silvia Regina Cavani Jorge
Source: Revista Brasileira de Terapia Intensiva. Unidades: FM, FCF
Subjects: FARMACOCINÉTICA, ANTIBIÓTICOS, UNIDADES DE TERAPIA INTENSIVA, PEDIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIRES, Frederico Ribeiro et al. Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against grampositive pathogens?. Revista Brasileira de Terapia Intensiva, v. 32, n. 3 p. 391-397, 2020Tradução . . Disponível em: https://doi.org/10.5935/0103-507X.20200067. Acesso em: 10 nov. 2024.
APA
Pires, F. R., Paula, S. I. de, Delgado, A. F., Carvalho, W. B. de, Duarte, N. J. C., Morales Júnior, R., & Santos, S. R. C. J. (2020). Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against grampositive pathogens? Revista Brasileira de Terapia Intensiva, 32( 3 p. 391-397). doi:10.5935/0103-507X.20200067
NLM
Pires FR, Paula SI de, Delgado AF, Carvalho WB de, Duarte NJC, Morales Júnior R, Santos SRCJ. Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against grampositive pathogens? [Internet]. Revista Brasileira de Terapia Intensiva. 2020 ; 32( 3 p. 391-397):[citado 2024 nov. 10 ] Available from: https://doi.org/10.5935/0103-507X.20200067
Vancouver
Pires FR, Paula SI de, Delgado AF, Carvalho WB de, Duarte NJC, Morales Júnior R, Santos SRCJ. Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against grampositive pathogens? [Internet]. Revista Brasileira de Terapia Intensiva. 2020 ; 32( 3 p. 391-397):[citado 2024 nov. 10 ] Available from: https://doi.org/10.5935/0103-507X.20200067
Trabalho de evento-resumo
Treatment of depression with clinical or psychiatric comorbidities: recommendations from high-quality clinical practice guidelines (2019)
Gabriel, Franciele Cordeiro; Fraguas Junior, Renerio ; Molino, Caroline de Godoi Rezende Costa; Santos, Nathalia Celini Leite; Valentim, Renata de Oliveira; Silva, Rafael Augusto Mantovani; Melo, Daniela Oliveira de ; Ribeiro, Eliane
Source: Abstracts. Conference titles: World Congress of Psychiatry/WPA. Unidades: FM, FCF
Subjects: DEPRESSÃO, PRÁTICA CLÍNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GABRIEL, Franciele Cordeiro et al. Treatment of depression with clinical or psychiatric comorbidities: recommendations from high-quality clinical practice guidelines. 2019, Anais.. Lisbon: European Federation of Psychiatric Trainees/EFPT, 2019. . Acesso em: 10 nov. 2024.
APA
Gabriel, F. C., Fraguas Junior, R., Molino, C. de G. R. C., Santos, N. C. L., Valentim, R. de O., Silva, R. A. M., et al. (2019). Treatment of depression with clinical or psychiatric comorbidities: recommendations from high-quality clinical practice guidelines. In Abstracts. Lisbon: European Federation of Psychiatric Trainees/EFPT.
NLM
Gabriel FC, Fraguas Junior R, Molino C de GRC, Santos NCL, Valentim R de O, Silva RAM, Melo DO de, Ribeiro E. Treatment of depression with clinical or psychiatric comorbidities: recommendations from high-quality clinical practice guidelines. Abstracts. 2019 ;[citado 2024 nov. 10 ]
Vancouver
Gabriel FC, Fraguas Junior R, Molino C de GRC, Santos NCL, Valentim R de O, Silva RAM, Melo DO de, Ribeiro E. Treatment of depression with clinical or psychiatric comorbidities: recommendations from high-quality clinical practice guidelines. Abstracts. 2019 ;[citado 2024 nov. 10 ]
Trabalho de evento-resumo periodico
Vancomycin dose adjustment in critically ill burn patients using the pharmacokinetic/pharmacodynamic approach against Gram-positive MIC 2 mg/l strains (2019)
Kupa, Leonard de Vinci Kanda; Silva Júnior, João Manoel da; Silva Junior, Elson Mendes da; Oliveira, Amanda Maria Ribas Rosa de; Gomides, Aline Sandre; Silva, Cristina Carvalho da; Ferreira, Gabriela Aparecida; Oliveira, Thiago Camara; Duarte, Nilo José Coelho; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Critical Care. Conference titles: International Symposium on Intensive Care and Emergency Medicine for Latin America. Unidades: FM, FCF
Subjects: UNIDADES DE TERAPIA INTENSIVA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KUPA, Leonard de Vinci Kanda et al. Vancomycin dose adjustment in critically ill burn patients using the pharmacokinetic/pharmacodynamic approach against Gram-positive MIC 2 mg/l strains. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-019-2503-9. Acesso em: 10 nov. 2024. , 2019
APA
Kupa, L. de V. K., Silva Júnior, J. M. da, Silva Junior, E. M. da, Oliveira, A. M. R. R. de, Gomides, A. S., Silva, C. C. da, et al. (2019). Vancomycin dose adjustment in critically ill burn patients using the pharmacokinetic/pharmacodynamic approach against Gram-positive MIC 2 mg/l strains. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1186/s13054-019-2503-9
NLM
Kupa L de VK, Silva Júnior JM da, Silva Junior EM da, Oliveira AMRR de, Gomides AS, Silva CC da, Ferreira GA, Oliveira TC, Duarte NJC, Gomez D de S, Santos SRCJ. Vancomycin dose adjustment in critically ill burn patients using the pharmacokinetic/pharmacodynamic approach against Gram-positive MIC 2 mg/l strains [Internet]. Critical Care. 2019 ; 23 res.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Vancouver
Kupa L de VK, Silva Júnior JM da, Silva Junior EM da, Oliveira AMRR de, Gomides AS, Silva CC da, Ferreira GA, Oliveira TC, Duarte NJC, Gomez D de S, Santos SRCJ. Vancomycin dose adjustment in critically ill burn patients using the pharmacokinetic/pharmacodynamic approach against Gram-positive MIC 2 mg/l strains [Internet]. Critical Care. 2019 ; 23 res.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Artigo de periodico
Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment (2019)
Monteiro, Lis Marie ; Löbenberg, Raimar ; Fotaki, Nikoletta; Araujo, Gabriel Lima Barros de ; Cotrim, Paulo César ; Bou-Chacra, Nadia Araci
Source: Journal of Global Antimicrobial Resistance. Unidades: FCF, FM
Subjects: QUITOSANA, LEISHMANIA, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEIRO, Lis Marie et al. Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment. Journal of Global Antimicrobial Resistance, v. 18, p. 279-283, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jgar.2019.06.006. Acesso em: 10 nov. 2024.
APA
Monteiro, L. M., Löbenberg, R., Fotaki, N., Araujo, G. L. B. de, Cotrim, P. C., & Bou-Chacra, N. A. (2019). Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment. Journal of Global Antimicrobial Resistance, 18, 279-283. doi:10.1016/j.jgar.2019.06.006
NLM
Monteiro LM, Löbenberg R, Fotaki N, Araujo GLB de, Cotrim PC, Bou-Chacra NA. Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment [Internet]. Journal of Global Antimicrobial Resistance. 2019 ; 18 279-283.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.jgar.2019.06.006
Vancouver
Monteiro LM, Löbenberg R, Fotaki N, Araujo GLB de, Cotrim PC, Bou-Chacra NA. Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment [Internet]. Journal of Global Antimicrobial Resistance. 2019 ; 18 279-283.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.jgar.2019.06.006
Trabalho de evento-resumo periodico
Extended two-hour infusion improves piperacillin effectiveness against susceptible strains in septic burn patients (2019)
Souza, Vanessa Kasubeck de; Silva Junior, Elson Mendes da; Matsuno, Victor Kaneko; Gomides, Aline Sandre; Silva Júnior, João Manoel da; Oliveira, Thiago Camara; Ferreira, Gabriela Aparecida; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Critical Care. Conference titles: International Symposium on Intensive Care and Emergency Medicine for Latin America. Unidades: FM, FCF
Subjects: BACTÉRIAS GRAM-NEGATIVAS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Vanessa Kasubeck de et al. Extended two-hour infusion improves piperacillin effectiveness against susceptible strains in septic burn patients. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-019-2503-9. Acesso em: 10 nov. 2024. , 2019
APA
Souza, V. K. de, Silva Junior, E. M. da, Matsuno, V. K., Gomides, A. S., Silva Júnior, J. M. da, Oliveira, T. C., et al. (2019). Extended two-hour infusion improves piperacillin effectiveness against susceptible strains in septic burn patients. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1186/s13054-019-2503-9
NLM
Souza VK de, Silva Junior EM da, Matsuno VK, Gomides AS, Silva Júnior JM da, Oliveira TC, Ferreira GA, Gomez D de S, Santos SRCJ. Extended two-hour infusion improves piperacillin effectiveness against susceptible strains in septic burn patients [Internet]. Critical Care. 2019 ; 23 20-21 res. P35.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Vancouver
Souza VK de, Silva Junior EM da, Matsuno VK, Gomides AS, Silva Júnior JM da, Oliveira TC, Ferreira GA, Gomez D de S, Santos SRCJ. Extended two-hour infusion improves piperacillin effectiveness against susceptible strains in septic burn patients [Internet]. Critical Care. 2019 ; 23 20-21 res. P35.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Trabalho de evento-resumo
Chemical composition and Trypanocidal activity evaluation of the volatile oil from Mentha pulegium L. (2019)
Tropéia, Naomi Crispim; Alcântara, Laura Maria ; Franco, Caio Haddad ; Moraes, Carolina Borsoi ; Fischer, Dominique Corinne Hermine
Source: Abstracts. Conference titles: International Phytocosmetics and Phytotherapy Congress/IPPC. Unidades: FCF, FM
Subjects: ANTIPROTOZOÁRIOS, MENTA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TROPÉIA, Naomi Crispim et al. Chemical composition and Trypanocidal activity evaluation of the volatile oil from Mentha pulegium L. 2019, Anais.. Recife: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, 2019. . Acesso em: 10 nov. 2024.
APA
Tropéia, N. C., Alcântara, L. M., Franco, C. H., Moraes, C. B., & Fischer, D. C. H. (2019). Chemical composition and Trypanocidal activity evaluation of the volatile oil from Mentha pulegium L. In Abstracts. Recife: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Tropéia NC, Alcântara LM, Franco CH, Moraes CB, Fischer DCH. Chemical composition and Trypanocidal activity evaluation of the volatile oil from Mentha pulegium L. Abstracts. 2019 ;[citado 2024 nov. 10 ]
Vancouver
Tropéia NC, Alcântara LM, Franco CH, Moraes CB, Fischer DCH. Chemical composition and Trypanocidal activity evaluation of the volatile oil from Mentha pulegium L. Abstracts. 2019 ;[citado 2024 nov. 10 ]
Trabalho de evento-resumo periodico
Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock (2019)
Kupa, Leonard de Vinci Kanda; Silva Júnior, João Manoel da; Silva Junior, Elson Mendes da; Oliveira, Amanda Maria Ribas Rosa de; Gomides, Aline Sandre; Silva, Cristina Carvalho da; Ferreira, Gabriela Aparecida; Oliveira, Thiago Camara; Duarte, Nilo José Coelho; Gomez, David de Souza; Guillaux, Camila Salinas; Santos, Silvia Regina Cavani Jorge
Source: Critical Care. Conference titles: International Symposium on Intensive Care and Emergency Medicine for Latin America. Unidades: FM, FCF
Subjects: SEPSE, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KUPA, Leonard de Vinci Kanda et al. Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-019-2503-9. Acesso em: 10 nov. 2024. , 2019
APA
Kupa, L. de V. K., Silva Júnior, J. M. da, Silva Junior, E. M. da, Oliveira, A. M. R. R. de, Gomides, A. S., Silva, C. C. da, et al. (2019). Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1186/s13054-019-2503-9
NLM
Kupa L de VK, Silva Júnior JM da, Silva Junior EM da, Oliveira AMRR de, Gomides AS, Silva CC da, Ferreira GA, Oliveira TC, Duarte NJC, Gomez D de S, Guillaux CS, Santos SRCJ. Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock [Internet]. Critical Care. 2019 ; 23 17 res. P31.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Vancouver
Kupa L de VK, Silva Júnior JM da, Silva Junior EM da, Oliveira AMRR de, Gomides AS, Silva CC da, Ferreira GA, Oliveira TC, Duarte NJC, Gomez D de S, Guillaux CS, Santos SRCJ. Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock [Internet]. Critical Care. 2019 ; 23 17 res. P31.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Trabalho de evento-resumo periodico
Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l (2019)
Pires, Frederico Ribeiro; Delgado, Artur Figueiredo ; Campos, Edvaldo Vieira de; Silva, Cristina Carvalho da; Fedeli, Juliana Gadelha; Duarte, Nilo José Coelho; Kupa, Leonard de Vinci Kanda; Matsuno, Victor Kaneko; Messiano, Claudia Garcia; Santos, Silvia Regina Cavani Jorge ; Gomez, David de Souza
Source: Critical Care. Conference titles: International Symposium on Intensive Care and Emergency Medicine for Latin America. Unidades: FCF, FM
Subjects: FARMACOCINÉTICA, STAPHYLOCOCCUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIRES, Frederico Ribeiro et al. Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l. Critical Care. London: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-019-2503-9. Acesso em: 10 nov. 2024. , 2019
APA
Pires, F. R., Delgado, A. F., Campos, E. V. de, Silva, C. C. da, Fedeli, J. G., Duarte, N. J. C., et al. (2019). Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l. Critical Care. London: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1186/s13054-019-2503-9
NLM
Pires FR, Delgado AF, Campos EV de, Silva CC da, Fedeli JG, Duarte NJC, Kupa L de VK, Matsuno VK, Messiano CG, Santos SRCJ, Gomez D de S. Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l [Internet]. Critical Care. 2019 ; 23 19-20 res. P34.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Vancouver
Pires FR, Delgado AF, Campos EV de, Silva CC da, Fedeli JG, Duarte NJC, Kupa L de VK, Matsuno VK, Messiano CG, Santos SRCJ, Gomez D de S. Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l [Internet]. Critical Care. 2019 ; 23 19-20 res. P34.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Trabalho de evento-resumo periodico
The pharmacokinetic/pharmacodynamic approach in pediatric septic burn patients to guarantee vancomycin effectiveness against Staphylococcus (2019)
Campos, Edvaldo Vieira de; Kupa, Leonard de Vinci Kanda; Macedo, Vedilaine Aparecida Bueno da Silva; Camargo, Thais Vieira de; Silva Júnior, João Manoel da; Silva, Cristina Carvalho da; Pereira Junior, José Gomes; Fedeli, Juliana Gadelha; Duarte, Nilo José Coelho; Santos, Silvia Regina Cavani Jorge ; Gomez, David de Souza
Source: Critical Care. Conference titles: International Symposium on Intensive Care and Emergency Medicine for Latin America. Unidades: FM, FCF
Subjects: FARMACOCINÉTICA, STAPHYLOCOCCUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Edvaldo Vieira de et al. The pharmacokinetic/pharmacodynamic approach in pediatric septic burn patients to guarantee vancomycin effectiveness against Staphylococcus. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-019-2503-9. Acesso em: 10 nov. 2024. , 2019
APA
Campos, E. V. de, Kupa, L. de V. K., Macedo, V. A. B. da S., Camargo, T. V. de, Silva Júnior, J. M. da, Silva, C. C. da, et al. (2019). The pharmacokinetic/pharmacodynamic approach in pediatric septic burn patients to guarantee vancomycin effectiveness against Staphylococcus. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1186/s13054-019-2503-9
NLM
Campos EV de, Kupa L de VK, Macedo VAB da S, Camargo TV de, Silva Júnior JM da, Silva CC da, Pereira Junior JG, Fedeli JG, Duarte NJC, Santos SRCJ, Gomez D de S. The pharmacokinetic/pharmacodynamic approach in pediatric septic burn patients to guarantee vancomycin effectiveness against Staphylococcus [Internet]. Critical Care. 2019 ; 23 19 res. P33.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Vancouver
Campos EV de, Kupa L de VK, Macedo VAB da S, Camargo TV de, Silva Júnior JM da, Silva CC da, Pereira Junior JG, Fedeli JG, Duarte NJC, Santos SRCJ, Gomez D de S. The pharmacokinetic/pharmacodynamic approach in pediatric septic burn patients to guarantee vancomycin effectiveness against Staphylococcus [Internet]. Critical Care. 2019 ; 23 19 res. P33.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1186/s13054-019-2503-9

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration